Cargando…
Contralateral breast cancer risk in patients with breast cancer and a germline-BRCA1/2 pathogenic variant undergoing radiation
BACKGROUND: Radiation-induced secondary breast cancer (BC) may be a concern after radiation therapy (RT) for primary breast cancer (PBC), especially in young patients with germline (g)BRCA–associated BC who already have high contralateral BC (CBC) risk and potentially increased genetic susceptibilit...
Autores principales: | van Barele, Mark, Akdeniz, Delal, Heemskerk-Gerritsen, Bernadette A M, Andrieu, Nadine, Noguès, Catherine, van Asperen, Christi J, Wevers, Marijke, Ausems, Margreet G E M, de Bock, Geertruida H, Dommering, Charlotte J, Gómez-García, Encarnacion B, van Leeuwen, Flora E, Mooij, Thea M, Easton, Douglas F, Antoniou, Antonis C, Evans, D Gareth, Izatt, Louise, Tischkowitz, Marc, Frost, Debra, Brewer, Carole, Olah, Edit, Simard, Jacques, Singer, Christian F, Thomassen, Mads, Kast, Karin, Rhiem, Kerstin, Engel, Christoph, de la Hoya, Miguel, Foretová, Lenka, Jakubowska, Anna, Jager, Agnes, Sattler, Margriet G A, Schmidt, Marjanka K, Hooning, Maartje J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637040/ https://www.ncbi.nlm.nih.gov/pubmed/37369040 http://dx.doi.org/10.1093/jnci/djad116 |
Ejemplares similares
-
Effects of chemotherapy on contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: A nationwide cohort study
por: Akdeniz, Delal, et al.
Publicado: (2021) -
Corrigendum to “The impact of menstruation persistence or recovery after chemotherapy on survival in young patients with hormone receptor negative breast cancer” [Breast 52 (2020) 102–109]
por: van Barele, Mark, et al.
Publicado: (2020) -
The impact of menstruation persistence or recovery after chemotherapy on survival in young patients with hormone receptor negative breast cancer
por: van Barele, Mark, et al.
Publicado: (2020) -
Risk of metachronous contralateral breast cancer in patients with primary invasive lobular breast cancer: Results from a nationwide cohort
por: Akdeniz, Delal, et al.
Publicado: (2022) -
Estrogens and Progestogens in Triple Negative Breast Cancer: Do They Harm?
por: van Barele, Mark, et al.
Publicado: (2021)